4/1
08:09 am
itrm
Iterum Therapeutics plc (NASDAQ: ITRM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Iterum Therapeutics plc (NASDAQ: ITRM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
3/28
07:09 am
itrm
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
3/28
07:00 am
itrm
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Medium
Report
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
3/21
04:30 pm
itrm
Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
Neutral
Report
Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
3/15
08:23 am
itrm
Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat [Yahoo! Finance]
Neutral
Report
Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat [Yahoo! Finance]
3/15
08:00 am
itrm
Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat
Neutral
Report
Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat
3/7
09:49 am
itrm
Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up [Yahoo! Finance]
Medium
Report
Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up [Yahoo! Finance]
3/6
12:35 pm
itrm
Iterum Therapeutics plc (NASDAQ: ITRM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Iterum Therapeutics plc (NASDAQ: ITRM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
3/6
08:11 am
itrm
Iterum Therapeutics Provides Business Update [Yahoo! Finance]
Medium
Report
Iterum Therapeutics Provides Business Update [Yahoo! Finance]
3/6
08:00 am
itrm
Iterum Therapeutics Provides Business Update
High
Report
Iterum Therapeutics Provides Business Update
2/7
08:14 am
itrm
Iterum Therapeutics plc (NASDAQ: ITRM) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $6.00 price target on the stock.
Neutral
Report
Iterum Therapeutics plc (NASDAQ: ITRM) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $6.00 price target on the stock.
2/1
03:13 pm
itrm
Steven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLC [Yahoo! Finance]
Low
Report
Steven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLC [Yahoo! Finance]
1/30
07:18 am
itrm
Iterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections [Yahoo! Finance]
Medium
Report
Iterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections [Yahoo! Finance]
1/30
07:00 am
itrm
Iterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
Medium
Report
Iterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections